IN VIVO ANTIBODIES FROM BIO X CELL
Recombinant PD-1: Consistent performance from pilot studies through translational research
PD-1 (CD279) is a central immune checkpoint receptor that downregulates T cell activity to maintain tolerance and prevent autoimmunity. By binding PD-L1 and PD-L2, PD-1 reduces T cell proliferation and cytokine production, an interaction tumors exploit to evade immune attack.
Bio X Cell recombinant anti-PD-1 antibodies deliver sequence-defined reproducibility, ultra-low endotoxin purity, and Fc-engineered formats, ensuring consistent performance from pilot studies through translational research.
All products listed on this site and sold through LAB-A-PORTER Limited are for research use only (RUO). Not for human use. Not for therapeutic or diagnostic use.
ABOUT BIO X CELL
Antibodies For In Vivo Research
Bio X Cell antibodies are formulated for in vivo experiments and used extensively in animal models of human disease. They feature greater than 95% purity, ultra-low endotoxin levels, and are presevative, stabilizer, and carrier protein-free. Bio X Cell has developed a wide range of antibodies for immuno-oncology, immunology, and neuroscience research. Their products are cited in over 15,000 publications that detail a broad range of applications, including in vivo cell-specific depletion, cytokine neutralization, immune checkpoint blockade, and more.
-
- Exceptional Purity
- Pathogen Free
- Ultra-low Endotoxin Level
- Advanced Binding Validation
- Low Protein Aggregation
- Marching Isotype Control Antibodies
All products listed on this site and sold through LAB-A-PORTER Limited are for research use only (RUO). Not for human use. Not for therapeutic or diagnostic use.